Contact Us: 1-800-981-9883
Laboratory Watch with
Dr. Chhieng
Laboratory
Watch with
Dr. Chhieng
Laboratory Watch–a new COLA blog for clinical laboratory professionals. It is intended to be an informative resource dedicated to helping pathologists, laboratory directors and clinical laboratory professionals perform their jobs better. Laboratory Watch will keep you and other laboratory professionals up-to-date on significant advancements in the field of laboratory science, the latest regulatory news and the opinions of experts in their field.
David Chhieng
MD, MBA, MSHI, MSEM, MLS, MDR
Since 2021
Dr. David Chhieng is the Chief Medical Officer of COLA. Before he joined COLA, he was a Professor, the Director of Anatomic Pathology and Pathology Informatics, and Vice Chair of Clinical Operation, of the Department of Pathology at the University of Washington in Seattle WA. Prior to that, he was the Director of Cytopathology at the Yale University and the Icahn School of Medicine at Mount Sinai.
Dr. Chhieng obtained his MD degree from the University of Hong Kong and completed several master degrees in Business Administration, Health Informatics Management, Engineering Management, Legal Studies and Dispute Resolution. His fellowship training in Surgical Pathology and Cytopathology at the Memorial Sloan Kettering Cancer Center and New York University, respectively. He is board certified in Anatomic and Clinical Pathology, Cytopathology, and Clinical Informatics. He has been a practicing surgical and cytopathologist for 20+ years and in a directorship position for 10+ years.
He has published 170+ peer-reviewed articles on the topics of cytopathology and surgical pathology. He has also co-authored several books and a number of book chapters. He has presented in many regional, national, and international pathology meetings and conferences. Dr. Chhieng has also served on a number of professional societies, including the ASCP Board of Directors; ASCP BOC Board of Governor. In addition, Dr. Chhieng has also served on the cytology test development and advisory committee of the American Board of Pathology, state commissioners for CAP Laboratory Accreditation Program, the Executive Board of ASC, and the work groups of the Bethesda System for Reporting Gynecology Cytology.
Patient Safety Awareness Week, celebrated every March, casts a spotlight on a critical aspect of healthcare: patient safety. It is a time when the healthcare community, including pathologists and laboratory professionals, renews its commitment to fostering an...
Welcome back to the third entry of our series on primary HPV testing in cervical cancer screening. In this installment, we take a retrospective look at how HPV testing has revolutionized cervical cancer detection since its introduction in the early 2000s. Applications...
In a groundbreaking discovery last November, a team of researchers from the University of Maryland in Baltimore unveiled two previously unknown viruses, aptly named “vampire viruses.” These intriguing entities engage in a fascinating act: one virus, the...
Welcome back to part two of our series on primary HPV testing in cervical cancer screening. In this blog, we will focus on the various FDA-approved Human Papillomavirus (HPV) assays available in the U.S. Human Papillomavirus and Cervical Cancer HPV...
Greetings and welcome to the Laboratory Watch Blog! Today marks the commencement of our series focusing on Primary Human Papillomavirus (HPV) Testing in the context of cervical cancer screening. As a cytopathologist, I regard this paradigm shift as especially...
The Complex World of Viral Hemorrhagic Fevers Viral hemorrhagic fevers (VHFs) represent a diverse spectrum of diseases impacting both animals and humans. VHFs are caused by five distinct families of RNA viruses: Filoviridae, Flaviviridae, Rhabdoviridae,...
Welcome to the final part of our series on Gain of Function Research (GOFR). This chapter highlights the National Science Advisory Board for Biosecurity’s (NSABB) newest recommendations, which seek to mitigate biosecurity and biosafety risks while advancing...
Welcome back to the fourth installment of our series focusing on Gain of Function Research (GOFR). In this entry, we turn our spotlight onto the current oversight frameworks in the United States designed to mitigate the biosecurity and biosafety risks inherent in...
Welcome back to our ongoing series exploring Gain of Function Research (GOFR). In this third installment, we venture onto the tightrope of balancing the inherent risks and benefits of GOFR, while acknowledging the challenges along the way. Piecing Together the...
Stay Informed!
Stay informed about the latest regulatory announcements, upcoming events, trending accreditation news and other laboratory topics.